High-resolution transrectal ultrasound: Pilot study of a novel technique for imaging clinically localized prostate cancer

被引:32
|
作者
Pavlovich, Christian P. [1 ]
Cornish, Toby C. [2 ]
Mullins, Jeffrey K. [1 ]
Fradin, Joel [3 ]
Mettee, Lynda Z. [1 ]
Connor, Jason T. [4 ,5 ]
Reese, Adam C. [1 ]
Askin, Frederic B. [2 ]
Luck, Rachael [2 ]
Epstein, Jonathan I. [1 ,2 ]
Burke, Harry B. [6 ,7 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA
[4] Berry Consultants, Orlando, FL USA
[5] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA
[6] Uniformed Serv Univ Hlth Sci, Biomed Informat Dept, Bethesda, MD 20814 USA
[7] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA
关键词
Diagnosis; Prostate cancer; Radical prostatectomy; Ultrasound; Sensitivity and specificity; TRANS-RECTAL SONOGRAPHY; COLOR DOPPLER; CONTRAST AGENT; POWER DOPPLER; BIOPSY; ULTRASONOGRAPHY; APPEARANCE; CARCINOMA; COHORT;
D O I
10.1016/j.urolonc.2013.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer. Methods and materials: Twenty-five men with known prostate cancer scheduled for radical prostatectomy were preoperatively imaged with both LoTRUS (5 MHz) and HiTRUS (21 MHz). Dynamic cine loops and still images for each modality were saved and subjected to blinded review by a radiologist looking for hypoechoic foci >= 5 mm in each sextant of the prostate. :Following prostatectomy, areas of prostate cancer >= 5 mm on pathologic review were anatomically correlated to LoTRUS and HiTRUS findings. The accuracy of LoTRUS and HiTRUS to visualize prostate cancer in each sextant of the prostate and to identify high-grade and locally advanced disease was assessed. The McNemar test was used to compare sensitivity and specificity and paired dichotomous outcomes between imaging modalities. Results: Among 69 sextants with pathologically identified cancerous foci at radical prostatecomy. HiTRUS visualized 45 and missed 24, whereas LoTRUS visualized 26 and missed 43. Compared with LoTRUS, HiTRUS demonstrated improved sensitivity (65.2% vs. 37.7%) and specificity (71.6% vs. 65.4%). HiTRUS's agreement with pathologic findings was twice as high as LoTRUS (P = 0.006). HiTRUS provided a nonsignificant increase in visualization of high-grade lesions (84% vs. 60%, P = 0.11). Conclusions: HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:34.e27 / 34.e32
页数:6
相关论文
共 50 条
  • [1] Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer
    Boutier, Romain
    Girouin, Nicolas
    Ben Cheikh, Alexandre
    Belot, Aurelien
    Rabilloud, Muriel
    Gelet, Albert
    Chapelon, Jean-Yves
    Rouviere, Olivier
    BJU INTERNATIONAL, 2011, 108 (11) : 1776 - 1781
  • [2] Performance Characteristics of Transrectal Shear Wave Elastography Imaging in the Evaluation of Clinically Localized Prostate Cancer: A Prospective Study
    Wei, Cheng
    Li, Chunhui
    Szewczyk-Bieda, Magdalena
    Upreti, Dilip
    Lang, Stephen
    Huang, Zhihong
    Nabi, Ghulam
    JOURNAL OF UROLOGY, 2018, 200 (03): : 549 - 557
  • [3] Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound
    Jung, Adam J.
    Coakley, Fergus V.
    Shinohara, Katsuto
    Carroll, Peter R.
    Kurhanewicz, John
    Cowan, Janet E.
    Westphalen, Antonio C.
    CLINICAL IMAGING, 2012, 36 (05) : 547 - 552
  • [4] Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging
    Novis, Maria Ines
    Baroni, Ronaldo Hueb
    de Oliveira Cerri, Luciana Mendes
    Mattedi, Romulo Loss
    Buchpiguel, Carlos Alberto
    CLINICS, 2011, 66 (01) : 27 - 34
  • [5] Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems
    Chen, Tong
    Wang, Fei
    Chen, Hanbing
    Wang, Meng
    Liu, Peiqing
    Liu, Songtao
    Zhou, Yibin
    Ma, Qi
    BMC UROLOGY, 2022, 22 (01)
  • [6] Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection
    Gupta, I
    Freid, B.
    Masarapu, V
    Machado, P.
    Trabulsi, E.
    Wallace, K.
    Halpern, E.
    Forsberg, F.
    UROLOGY, 2020, 138 : 106 - 112
  • [7] Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: Eight-year experience
    Uchida, Toyoaki
    Shoji, Sunao
    Nakano, Mayura
    Hongo, Satoko
    Nitta, Masahiro
    Murota, Akiko
    Nagata, Yoshihiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (11) : 881 - 886
  • [8] Diagnostic Performance of Multiparametric Transrectal Ultrasound in Localized Prostate Cancer: A Comparative Study With Magnetic Resonance Imaging
    Zhang, Mingbo
    Tang, Jie
    Luo, Yukun
    Wang, Yiru
    Wu, Meng
    Memmott, Benjamin
    Gao, Jing
    JOURNAL OF ULTRASOUND IN MEDICINE, 2019, 38 (07) : 1823 - 1830
  • [9] Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy
    Rastinehad, Ardeshir R.
    Turkbey, Baris
    Salami, Simpa S.
    Yaskiv, Oksana
    George, Arvin K.
    Fakhoury, Mathew
    Beecher, Karin
    Vira, Manish A.
    Kavoussi, Louis R.
    Siegel, David N.
    Villani, Robert
    Ben-Levi, Eran
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1749 - 1754
  • [10] Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
    Grey, Alistair D. R.
    Connor, Martin J.
    Tam, Joseph
    Loch, Tillmann
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1492 - 1500